Home LiteratureArticle Details
PMID: 6915939 Published · ppublish English Journal Article

Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.

The Journal of clinical investigation ·Vol. 69 ·No. 2 ·1982-02-00 ·Pages 337-46

Parker CJ, Baker PJ, Rosse WF

Abstract

To investigate the greater fixation of C3 to the erythrocytes of patients with paroxysmal nocturnal hemoglobinuria (PNH) upon activation of complement, we have examined the formation and the reaction of the C3 nephritic factor-stabilized alternative pathway convertase made with purified components on normal and PNH erythrocytes. Each convertase complex converts four to five times more fluid-phase C3 to C3b when affixed to a PNH cell than when affixed to a normal cell. The greater activity of the convertase on PNH cells is not due to differences in the intrinsic or extrinsic stability of the convertase complex. The excessive binding of C3 to PNH cell si due to this increased conversion of fluid-phase C3, because the efficiency of binding of nascent C3b was identical for the two cell types. This is the first instance in which the enzyme activity of a complement complex has been shown to be increased by being affixed to an abnormal surface.

MeSH Terms
Complement Activating Enzymes/metabolism Complement Activation Complement C3 Nephritic Factor/metabolism Complement C3-C5 Convertases/biosynthesis,metabolism Complement C3b/metabolism Complement Factor B/metabolism Complement Pathway, Alternative Erythrocytes/enzymology Hemagglutination Hemoglobinuria, Paroxysmal/blood,enzymology Humans Receptors, Complement
Chemicals
Complement C3 Nephritic Factor Receptors, Complement Complement C3b Complement Activating Enzymes Complement C3-C5 Convertases Complement Factor B
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Parker C J
Baker P J
Rosse W F
References (36)
36 references, click to expand
  1. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.
    J Clin Invest. 1966 May;45(5):736-48 PMID: 5935361
  2. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis.
    J Clin Invest. 1966 May;45(5):749-57 PMID: 4956901
  3. Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.
    Biochem Biophys Res Commun. 1967 Sep 7;28(5):815-20 PMID: 4861258
  4. Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations.
    Blood. 1969 Apr;33(4):607-16 PMID: 5776206
  5. The C3-activator system: an alternate pathway of complement activation.
    J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s PMID: 4105810
  6. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    J Clin Invest. 1973 May;52(5):1129-37 PMID: 4700488
  7. Variations in the red cells in paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 1973 Mar;24(3):327-42 PMID: 4713634
  8. Surface properties of erythrocytes: normal, paroxysmal nocturnal hemoglobinuria and glutathione-treated cells.
    Biochim Biophys Acta. 1973 Oct 11;323(2):194-206 PMID: 4752282
  9. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    J Clin Invest. 1974 Jan;53(1):31-43 PMID: 4855546
  10. The population of cells in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis: significance and mechanism of increased immune lysis.
    Br J Haematol. 1974 Oct;28(2):181-90 PMID: 4473995
  11. Interaction of C3b, B, and D in the alternative pathway of complement activation.
    J Immunol. 1975 Oct;115(4):1108-13 PMID: 240884
  12. Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages.
    J Exp Med. 1975 Dec 1;142(6):1520-33 PMID: 1194857
  13. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    J Immunol. 1976 Sep;117(3):830-4 PMID: 956655
  14. Third component of human complement: purification from plasma and physicochemical characterization.
    Biochemistry. 1976 Oct 5;15(20):4513-21 PMID: 823964
  15. Nephritic factor: its structure and function and its relationship to initiating factor of the alternative pathway.
    Scand J Immunol. 1976;5(6-7):705-13 PMID: 62386
  16. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
    Proc Natl Acad Sci U S A. 1977 Apr;74(4):1683-7 PMID: 266208
  17. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    J Exp Med. 1977 Jul 1;146(1):22-33 PMID: 559720
  18. Interaction between the third complement protein and cell surface macromolecules.
    Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701-5 PMID: 268620
  19. Heterogeneity of nephritic factor and its identification as an immunoglobulin.
    Proc Natl Acad Sci U S A. 1977 Sep;74(9):3980-3 PMID: 269447
  20. Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor.
    J Immunol. 1978 Apr;120(4):1389-94 PMID: 76663
  21. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Proc Natl Acad Sci U S A. 1978 Apr;75(4):1971-5 PMID: 273923
  22. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20 PMID: 276881
  23. The binding of activated C3 to polysaccharides and immunoglobulins.
    J Immunol. 1978 Dec;121(6):2566-72 PMID: 722084
  24. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.
    J Immunol. 1979 Jan;122(1):75-81 PMID: 762425
  25. Relation between low erythrocyte acetylcholinesterase activity and membrane lipids in paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 1979 Mar;41(3):383-91 PMID: 427042
  26. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    J Clin Invest. 1979 Aug;64(2):428-33 PMID: 457861
  27. The lipids of the erythrocyte in paroxysmal nocturnal hemoglobinuria.
    Am J Hematol. 1978;5(4):323-33 PMID: 753102
  28. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.
    J Immunol. 1979 Sep;123(3):1388-94 PMID: 38283
  29. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    J Exp Med. 1979 Nov 1;150(5):1202-15 PMID: 501288
  30. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
    J Immunol. 1980 Feb;124(2):977-82 PMID: 7356723
  31. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71 PMID: 293688
  32. Inhibitors of complement derived from the erythrocyte membrane in paroxysmal nocturnal hemoglobinuria.
    Blood. 1980 May;55(5):772-6 PMID: 7362868
  33. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    N Engl J Med. 1980 Jul 31;303(5):259-63 PMID: 6900901
  34. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    J Exp Med. 1980 Jul 1;152(1):20-30 PMID: 6967510
  35. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
    J Exp Med. 1980 Dec 1;152(6):1625-44 PMID: 6450259
  36. Paroxysmal nocturnal hemoglobinuria. II. Erythrocyte acetylcholinesterase defect.
    Am J Med. 1959 Sep;27:401-10 PMID: 13795054
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1982-02-00
Pages
337-46
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC370983
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com